State revokes Delta marijuana manufacturing license

State regulators revoked a manufacturing license for a cannabis company this week.

Delta Extraction, LLC was reportedly found to have violated several of Missouri's cannabis policies. The revocation takes effect Dec. 2.

According to a news release from the Division of Cannabis Regulation, Delta violated several state regulations, including failing to ensure it used marijuana products and THC produced in Missouri.

Although that's the most-talked-about issue in this case, the division said it's just the tip of the iceberg.

"While Delta Extraction's use of out-of-state cannabis in our regulated system has been well-publicized and is a critical issue, DCR also found numerous other violations of rules at this facility. The Missouri Constitution charges the Department with ensuring the safety of marijuana products and the safety and security of marijuana facilities through enforcement of rules," DCR Director Amy Moore said in a statement. "We must be clear on this: Businesses that choose to participate in Missouri's marijuana industry do not get to decide which rules and which parts of Article XIV they want to follow."

Other violations listed by the division include falsifying seed-to-sale tracking data, not ensuring its product is traceable through state systems, failing to have products compliance-tested, packaging products in a false or misleading manner, violating several security measures and not requesting division approval of changes to space use.

Delta has been in the division's sites for several months, having taken center stage in an August product recall that was partially rolled back recently. More than 45,000 recalled products are still up in the air, and a state hearing is set for next month.

Representatives for Delta could not be reached for comment.

Missouri voters passed Amendment 3 last November, amending the state constitution to allow for the sale and use of recreational marijuana for adults ages 21 and older four years after legalizing the medicinal industry.